Keith Mankowitz is a Cardiology physician affiliated with St. Luke's Hospital. OpenAlex indexes 8 publications with 260 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
121 Saint Lukes Center Dr
Ste 303
Chesterfield, MO 630173509
Telephone
314-434-3278Registry record last updated 3 Jul 2014.
Industry payments
48 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202512 payments
- Novartis Pharmaceuticals CorporationProgram year202526 payments
- Novo Nordisk IncProgram year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.6%Beta blocker16.7%Metoprolol Succinate41%Carvedilol27%Metoprolol Tartrate18%Atenolol7%Sotalol3%Nebivolol Hcl2%Propranolol Hcl2%Acebutolol Hcl1%Part D<11 patientsStatin13.7%Atorvastatin Calcium59%Rosuvastatin Calcium28%Pravastatin Sodium6%Simvastatin5%Lovastatin1%Part D<11 patients+ 22 more classes in this area
Blood & clotting
12.4%Factor Xa inhibitor9.5%Eliquis82%Xarelto18%Part D≥229 patientsP2Y12 inhibitor1.8%Clopidogrel88%Brilinta8%Prasugrel Hcl4%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
9.5%Potassium supplement5.1%Potassium Chloride96%Klor-Con M204%Part D≥233 patientsSGLT2 inhibitor3%Farxiga56%Jardiance38%Dapagliflozin3%Inpefa3%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comprehensive Framework of Heart Failure with Preserved Ejection Fraction Management for Hospitalists: A Scoping Review
Journal of Brown Hospital Medicine
2026 - The effects of dual chamber pacing on the severity of mitral regurgitation in patients with hypertrophic cardiomyopathy
Journal of the American College of Cardiology
1998
Similar KOLs
Other experts from the same institution or the same specialty.
Constance Haan, MD
St. Luke's Hospital
Athanasios Fassas
St. Luke's Hospital
Αthanasios Fassas
St. Luke's Hospital
John W Gregory
St. Luke's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”